Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Evofem Biosciences, Inc.

(Exact name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation Rule	Amount Registered(1)			Proposed Maximum Offering Price Per Unit		Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee
Fees to be Paid	Debt	Common Stock	457(c)(2)		7,983,286	(3)	$	0.7943	$	6,341,124.07	$	0.0001102	$	698.79
	Equity	Common Stock	457(c)(2)		3,336,730	(4)	$	0.7943	$	2,650,364.64	$	0.0001102	$	292.07
	Total Offering Amounts							—	$	8,991,488.71		—	$	990.86
	Total Fees Previously Paid							—		—		—		—
	Total Fee Offsets							—		—		—		—
	Net Fee Due							—		—		—	$	990.86

(1)	Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional shares of common stock of Evofem Biosciences, Inc. (the “Registrant”) that become issuable with respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other transaction effected without the Registrant’s receipt of consideration that results in an increase in the number of outstanding shares of Registrant’s common stock.
(2)	Estimated in accordance with Rules 457(c) solely for purposes of calculating the registration fee on the basis of $0.79, the weighted average of the high and low prices of the Registrant’s common stock as reported on the OTCQB on July 3, 2023.
(3)	Consists of 7,983,286 shares of common stock registered for resale by the selling securityholder named in this registration statement, issuable upon the conversion of senior subordinated notes.
(4)	Consists of 3,336,730 shares of common stock registered for resale by the selling securityholder named in this registration statement, issuable upon the exercise of outstanding warrants.